| Date Filed | Type | Description |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| HOWARD RUDY (CFO) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 400,000 options to buy
@ $1.67, valued at
$668k
|
|
| 02/02/2023 |
4
| Dove Leonard Scott (COO) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 400,000 options to buy
@ $1.67, valued at
$668k
|
|
| 10/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2022 |
4
| Kirk Sigurd (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 97,063 options to buy
@ $0.9152, valued at
$88.8k
|
|
| 09/26/2022 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 97,063 options to buy
@ $0.9152, valued at
$88.8k
|
|
| 09/26/2022 |
4
| Zhang Eric (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 97,063 options to buy
@ $0.9152, valued at
$88.8k
|
|
| 09/26/2022 |
4
| ESHELMAN FREDRIC N (Executive Chairman) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 97,063 options to buy
@ $0.9152, valued at
$88.8k
|
|
| 09/26/2022 |
4
| Giaccia Amato (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 97,063 options to buy
@ $0.9152, valued at
$88.8k
|
|
| 09/26/2022 |
4
| Ho Peter Tai-Ching (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 97,063 options to buy
@ $0.9152, valued at
$88.8k
|
|
| 09/26/2022 |
4
| Hohneker John (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 97,063 options to buy
@ $0.9152, valued at
$88.8k
|
|
| 07/05/2022 |
4
| Geller Robert B. (Chief Medical Officer) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 200,000 options
@ $0.934, valued at
$186.8k
|
|
| 07/05/2022 |
3
| Geller Robert B. (Chief Medical Officer) has filed a Form 3 on Aravive, Inc. |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/04/2022 |
4
| ESHELMAN FREDRIC N (Executive Chairman of Board) has filed a Form 4 on Aravive, Inc.|
Txns:
| Exercised 4,545,455 options to buy
@ $0.0001, valued at
$454.5 |
|
| 03/22/2022 |
4
| Dove Leonard Scott (COO) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 200,000 options to buy
@ $1.89, valued at
$378k
|
|
| 03/22/2022 |
3
| Dove Leonard Scott (COO) has filed a Form 3 on Aravive, Inc. |
| 01/25/2022 |
4
| McIntyre Gail Frances (CEO and President) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 425,000 options to buy
@ $2.18, valued at
$926.5k
|
|
| 01/25/2022 |
4
| Shah Vinay (CFO) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 175,000 options to buy
@ $2.18, valued at
$381.5k
|
|
| 01/25/2022 |
4
| Rangwala Reshma (Chief Medical Officer) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 175,000 options to buy
@ $2.18, valued at
$381.5k
|
|
| 01/05/2022 |
4
| ESHELMAN FREDRIC N (Executive Chairman of Board) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 4,545,455 options to buy
@ $0.0001, valued at
$454.5 |
|
| 12/23/2021 |
4
| Giaccia Amato (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Gifted 48,366 shares
@ $0 |
|
| 12/02/2021 |
4
| Giaccia Amato (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Sold 252 shares
@ $3.22, valued at
$811.4
Sold 2,954 shares
@ $3.22, valued at
$9.5k
Sold 39 shares
@ $3.22, valued at
$125.6
Exercised 12,350 options
@ $0.06, valued at
$741
Exercised 38,761 options
@ $0.24, valued at
$9.3k
Exercised 500 options
@ $0.24, valued at
$120 |
|
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
4
| Giaccia Amato (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 22,812 options
@ $3.97, valued at
$90.6k
|
|
|